ID   UCLA 1
AC   CVCL_9951
SY   UCLA1
DR   GEO; GSM1395311
DR   ISCR; 1412
DR   NIHhESC; NIHhESC-10-0058
DR   SKIP; SKIP001356
DR   Wikidata; Q54989635
RX   PubMed=22058289;
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0058.
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
RX   PubMed=22058289; DOI=10.1093/hmg/ddr506;
RA   Diaz Perez S.V., Kim R., Li Z.-W., Marquez V.E., Patel S., Plath K.,
RA   Clark A.T.;
RT   "Derivation of new human embryonic stem cell lines reveals rapid
RT   epigenetic progression in vitro that can be prevented by chemical
RT   modification of chromatin.";
RL   Hum. Mol. Genet. 21:751-764(2012).
//
RX   PubMed=28445466; DOI=10.1038/nature22312;
RA   Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C.,
RA   Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G.,
RA   Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A.,
RA   Eggan K.C.;
RT   "Human pluripotent stem cells recurrently acquire and expand dominant
RT   negative P53 mutations.";
RL   Nature 545:229-233(2017).
//